{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:50:37Z","timestamp":1789537837075,"version":"build-2803163510"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"Objective<\/jats:title>Patients with primary aldosteronism (PA) have a high prevalence of osteoporosis (OP) and fractures (Fx). We evaluated the presence of PA in patients admitted to our metabolic bone disease outpatient clinic.<\/jats:p><\/jats:sec>Design<\/jats:title>Study conducted on an in- and outpatient basis in a referral Italian endocrinology unit.<\/jats:p><\/jats:sec>Methods<\/jats:title>A total of 2632 patients were evaluated. 2310 were excluded because they were taking drugs known to affect bone or mineralocorticoids metabolism or were diagnosed to have a secondary cause of osteoporosis. The remaining 322 subjects (304 females, 18 males) took part in the study. Bone mineral density (BMD) and thoracic and lumbar spine vertebral morphometry were performed by dual X-ray absorptiometry. All patients were screened for PA with aldosterone-to-renin ratio. In those who had positive results, confirmatory tests were performed.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 322 subjects, 213 were osteoporotics and 109 were not. PA was diagnosed in eleven out of 213 osteoporotic patients (5.2%) and one out of 109 non-osteoporotic subjects (0.9%,P<\/jats:italic>\u2009=\u20090.066). PA was observed in the 26.1% of patients with the concomitant presence of osteoporosis, hypertension and hypercalciuria. Compared with patients without PA, patients with PA had mean values of urinary calcium excretion, 4.8\u2009\u00b1\u20092.5\u2009mmol\/day vs 7.6\u2009\u00b1\u20093.2\u2009mmol\/day,P<\/jats:italic>\u2009<\u20090.001 and serum PTH levels, 5.4\u2009pmol\/L vs 7.3\u2009pmol\/L,P<\/jats:italic>\u2009<\u20090.01, significantly higher.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>PA should be considered among the causes of secondary OP.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-17-0417","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:10:13Z","timestamp":1502323813000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":45,"title":["Primary aldosteronism as a cause of secondary osteoporosis"],"prefix":"10.1093","volume":"177","author":[{"given":"Antonio Stefano","family":"Salcuni","sequence":"first","affiliation":[{"name":"1Endocrinology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Carnevale","sequence":"additional","affiliation":[{"name":"2Internal Medicine Unit, \u2018Casa Sollievo della Sofferenza\u2019, IRCCS, San Giovanni Rotondo (FG), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Battista","sequence":"additional","affiliation":[{"name":"1Endocrinology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Palmieri","sequence":"additional","affiliation":[{"name":"3Unit of Endocrinology and Metabolic Diseases, Fondazione IRCCS C\u00e0 Granda \u2013 Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Eller-Vainicher","sequence":"additional","affiliation":[{"name":"3Unit of Endocrinology and Metabolic Diseases, Fondazione IRCCS C\u00e0 Granda \u2013 Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Guarnieri","sequence":"additional","affiliation":[{"name":"4Medical Genetics Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Pugliese","sequence":"additional","affiliation":[{"name":"1Endocrinology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"5Radiology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Desina","sequence":"additional","affiliation":[{"name":"6Clinical Pathology Unit, \u2018Casa Sollievo della Sofferenza\u2019, IRCCS, San Giovanni Rotondo (FG), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine and Medical Disciplines, \u2018Sapienza\u2019, Rome University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[{"name":"3Unit of Endocrinology and Metabolic Diseases, Fondazione IRCCS C\u00e0 Granda \u2013 Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[{"name":"1Endocrinology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"ref111","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semnephrol.2008.01.005","article-title":"New insights into the pathogenesis of idiopathic hypercalciuria.","volume":"28","year":"2008","journal-title":"Seminars in Nephrology"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref291","doi-asserted-by":"publisher","first-page":"2004287","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism of : and","journal-title":"American Journal Physiology Heart Circulatory Physiology"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semi-quantitative technique","volume":"8","year":"1993","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","year":"2013","journal-title":"Osteoporosis International"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jbmr.333","article-title":"Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations","volume":"26","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-13-0102","article-title":"Prevalence of subclinical contributors to low bone mineral density and\/or fragility fracture","volume":"169","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone","volume":"52","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"ref131","first-page":"352","article-title":"Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily","volume":"18","year":"2014","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"ref421","first-page":"352","article-title":"Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily","volume":"18","year":"2014","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","article-title":"Diuretics and bone loss in rats with aldosteronism","volume":"46","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","year":"2013","journal-title":"Osteoporosis International"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","year":"2011","journal-title":"Hypertension Research"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-147-8-200710160-00006","article-title":"Subclinical hypercortisolism among outpatients referred for osteoporosis","volume":"147","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone","volume":"16","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","year":"2011","journal-title":"Hypertension Research"},{"key":"ref341","first-page":"836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","year":"2014","journal-title":"International Journal of Endocrinology"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"34","year":"2013","journal-title":"European Heart Journal"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone","volume":"52","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"ref301","doi-asserted-by":"publisher","first-page":"201297","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism : cross - sectional and interventional data from the GECOH Study of and","journal-title":"Journal Clinical Endocrinology Metabolism"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00198-003-1521-1","article-title":"Definition of a population specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)","volume":"14","year":"2003","journal-title":"Osteoporosis International"},{"key":"ref231","doi-asserted-by":"publisher","first-page":"2015173","DOI":"10.1530\/EJE-15-0118","article-title":"of endocrine disease secondary osteoporosis pathophysiology management of","author":"MirzaFCanalisE","journal-title":"Management European Journal Endocrinology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-147-8-200710160-00006","article-title":"Subclinical hypercortisolism among outpatients referred for osteoporosis","volume":"147","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"34","year":"2013","journal-title":"European Heart Journal"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"201297","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism : cross - sectional and interventional data from the GECOH Study of and","journal-title":"Journal Clinical Endocrinology Metabolism"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semnephrol.2008.01.005","article-title":"New insights into the pathogenesis of idiopathic hypercalciuria.","volume":"28","year":"2008","journal-title":"Seminars in Nephrology"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2265.2008.03213.x","article-title":"Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases","volume":"69","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00198-003-1521-1","article-title":"Definition of a population specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)","volume":"14","year":"2003","journal-title":"Osteoporosis International"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone","volume":"16","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-13-0102","article-title":"Prevalence of subclinical contributors to low bone mineral density and\/or fragility fracture","volume":"169","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension","volume":"207","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/10408360590913533","article-title":"Bone disease in primary hypercalciuria","volume":"42","year":"2005","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref471","doi-asserted-by":"publisher","first-page":"200528","DOI":"10.1007\/BF03347215","article-title":"Prevalence of hypercalcemia in hospitalised patients : effects of correction for serum albumin values of Investigation","journal-title":"Journal Endocrinological"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/10408360590913533","article-title":"Bone disease in primary hypercalciuria","volume":"42","year":"2005","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD.","volume":"18","year":"2015","journal-title":"Journal of Clinical Densitometry"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD.","volume":"18","year":"2015","journal-title":"Journal of Clinical Densitometry"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jbmr.333","article-title":"Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations","volume":"26","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension","volume":"207","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2265.2008.03213.x","article-title":"Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases","volume":"69","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"ref371","article-title":"Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism.","year":"2016","journal-title":"Minerva Endocrinologica"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"200528","DOI":"10.1007\/BF03347215","article-title":"Prevalence of hypercalcemia in hospitalised patients : effects of correction for serum albumin values of Investigation","journal-title":"Journal Endocrinological"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semi-quantitative technique","volume":"8","year":"1993","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref81","article-title":"Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism.","year":"2016","journal-title":"Minerva Endocrinologica"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","article-title":"Diuretics and bone loss in rats with aldosteronism","volume":"46","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"ref01","doi-asserted-by":"publisher","first-page":"2004287","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism of : and","journal-title":"American Journal Physiology Heart Circulatory Physiology"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref51","first-page":"836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","year":"2014","journal-title":"International Journal of Endocrinology"},{"key":"ref521","doi-asserted-by":"publisher","first-page":"2015173","DOI":"10.1530\/EJE-15-0118","article-title":"of endocrine disease secondary osteoporosis pathophysiology management of","author":"MirzaFCanalisE","journal-title":"Management European Journal Endocrinology"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/177\/5\/EJE-17-0417.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-17-0417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T03:49:20Z","timestamp":1719373760000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/177\/5\/431\/6655235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":58,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/eje-17-0417","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}